explored plasma biomarkers in NSCLC patients with the help of multiplex immunoassays and mass spectrometry, and found that in male, sFas, MMP-9, and PAI-1 had higher expression, while in female, sCD40 had higher expression compared to that of healthy volunteers (56). The gene discussed is MMP9; the disease is non-small cell lung carcinoma.